Response by Pei et al. to letters regarding article, "Pharmacokinetic study of imrecoxib in patients with renal insufficiency"

Qi Pei¹, Jin-Lian Xie^{1

2}, Hao Zhang³, Guo-Ping Yang^{4

5}

Affiliations

¹ Center for Clinical Pharmacology, The Third Xiangya Hospital, Central South University, Changsha, 410013, Hunan, China.
² School of Pharmaceutical Science, Central South University, Changsha, China.
³ Department of Nephrology, The Third Xiangya Hospital, Central South University, Changsha, 410013, China.
⁴ Center for Clinical Pharmacology, The Third Xiangya Hospital, Central South University, Changsha, 410013, Hunan, China. ygp9880@126.com.
⁵ School of Pharmaceutical Science, Central South University, Changsha, China. ygp9880@126.com.

Comment

Qi Pei et al. Eur J Clin Pharmacol. 2020 Mar.

. 2020 Mar;76(3):473-474.

doi: 10.1007/s00228-019-02826-7. Epub 2020 Jan 2.

Qi Pei¹, Jin-Lian Xie^{1

2}, Hao Zhang³, Guo-Ping Yang^{4

5}

¹ Center for Clinical Pharmacology, The Third Xiangya Hospital, Central South University, Changsha, 410013, Hunan, China.
² School of Pharmaceutical Science, Central South University, Changsha, China.
³ Department of Nephrology, The Third Xiangya Hospital, Central South University, Changsha, 410013, China.
⁴ Center for Clinical Pharmacology, The Third Xiangya Hospital, Central South University, Changsha, 410013, Hunan, China. ygp9880@126.com.
⁵ School of Pharmaceutical Science, Central South University, Changsha, China. ygp9880@126.com.

No abstract available

Comment on

Pharmacokinetic study of imrecoxib in patients with renal insufficiency.
Pei Q, Xie JL, Huang J, Liu WY, Yang XY, Wang Y, Li W, Tan HY, Zhang H, Yang GP. Pei Q, et al. Eur J Clin Pharmacol. 2019 Oct;75(10):1355-1360. doi: 10.1007/s00228-019-02698-x. Epub 2019 Jun 27. Eur J Clin Pharmacol. 2019. PMID: 31243478 Clinical Trial.